Litcius/Paper detail

Targeted intestinal barrier repair via probiotic-derived engineered outer membrane vesicles: A 3A1M strategy with antioxidant, anti-inflammatory, anti-ferroptotic, and microbiome modulation effects

Yu Li, He Zhang, Chengge Shi, Qiang Zhou, Jiayu Li, Bin Lü, Hongyang Lu, Ting Jin, Yinci Zhu, Tianci Zuo, Mengzhu Xu, Mingli Su, Yanmei Zhang, Quazi T.H. Shubhra, Xiaowen Hu, Hui Deng, Xiaojun Cai

2026Acta Pharmaceutica Sinica B7 citationsDOIOpen Access PDF

Abstract

Intestinal barrier disruption, driven by oxidative stress, ferroptosis, immune imbalance, and gut microbiota dysbiosis, plays a crucial role in inflammatory bowel disease (IBD) pathogenesis. Current treatments are often ineffective and cause side effects, emphasizing the need for novel therapies. Here, we have developed an engineered probiotic-derived outer membrane vesicle (OMV), GDO@CM, combining antioxidant gallic acid (GA) and anti-inflammatory H 2 S for targeted intestinal barrier repair. Constructed from Escherichia coli Nissle 1917 (EcN)-derived OMVs, GA and DATS are incorporated into the hydrophilic inner cavity and lipid bilayer, respectively, while mannose-decorated chitosan (CM) is electrostatically attached to the OMVs surface, enhancing stability and enabling targeted delivery to damaged colonic lesions. GDO@CM efficiently enters activated immune cells and epithelial cells, where GA scavenges reactive oxygen species and inhibits ferroptosis, while H 2 S amplifies anti-inflammatory effects. OMVs further synergize with GA and DATS to suppress pathogenic bacteria. These combined actions facilitate effective barrier repair and alleviate IBD symptoms. Single-cell RNA sequencing reveals that GDO@CM reduces inflammation, increases the proportion of reparative M2 macrophages and intestinal stem cells, and promotes epithelial cell proliferation via the APP/CD74 axis. Our findings establish GDO@CM as a promising multi-target therapeutic for IBD, offering a novel strategy for intestinal barrier restoration. Engineered OMVs-based nanoplatform GDO@CM delivers antioxidant gallic acid and anti-inflammatory H 2 S to effectively restore intestinal barrier integrity, modulate immunity, inhibit ferroptosis, and rebalance gut microbiota, thereby alleviating inflammatory bowel disease.

Topics & Concepts

ChemistryCell biologyInflammatory bowel diseaseImmune systemBacterial outer membraneTight junctionInflammationReactive oxygen speciesStem cellIntestinal mucosaMicrobiomeCancer researchMicrobiologyInflammatory Bowel DiseasesAntioxidantGut floraOxidative stressOxidative phosphorylationBiochemistryVesicleGut microbiota and healthFerroptosis and cancer prognosisImmune cells in cancer
Targeted intestinal barrier repair via probiotic-derived engineered outer membrane vesicles: A 3A1M strategy with antioxidant, anti-inflammatory, anti-ferroptotic, and microbiome modulation effects | Litcius